Globally, glaucoma cases continue to rise. As of 2010, there are 44.7 million people in the world with open angle glaucoma. By 2020, this is projected to increase to 58.6 million worldwide and 3.4 million in the United States alone. (Source: British Journal of Ophthalmology)
The disease affects about two per cent of the world’s population and can lead to blindness. Existing treatments have serious side effects or other problems such as compliance. There have been no new therapies in the last decade.
EyeTechCare has developed a non-invasive approach based on ultrasound that takes just two minutes. In trials, HIFU (High Intensity Focused Ultrasound) has so far proved to be safe, effective and painless. This procedure is also automated, reproducible and fast.
During the 5th World Glaucoma Congress in Vancouver http://www.globalaigs.org/WGC/WGC2013/index.php July 17-20, EyeTechCare will hold a symposium to discuss the latest developments in this new approach: “UC3: A Progress Report”.
The symposium will be chaired by Dr Robert Weinreb, distinguished Professor of ophthalmology at UC San Diego, Director of the Shiley Eye Center and of the Hamilton Glaucoma Center.
Speakers include:
· Dr. Tarek Shaarawy, Head of the glaucoma unit, University Hospital of Geneva
· Dr. Florent Aptel, Ophthalmologist, Grenoble University Hospital
· Dr. Leon Au, Ophthalmologist, Manchester Royal Eye Hospital
· Prof. Shlomo Melamed, Director of the Sam Rothberg Brother Glaucoma Center, Tel-Aviv
The following subjects will be debated:
· UC3 (Ultrasound Circular Cyclo Coagulation): results of the EyeMUST study
· Learning HIFU
· One-year results of HIFU in refractory glaucoma: where do we go from here?
Venue: WGC, Vancouver Convention Centre, Room 121- 122
Date: Thursday, July 18th
Time: 6 to 7pm
Address: 1055 Canada Place, Vancouver, BC V6C 0C3, Canada
EyeTechCare Booth No.: 304
How to get there: http://www.globalaigs.org/WGC/WGC2013/index.php?page=venue
